Citations |
- Akiyama Y et al. Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells. J Transl Med. 3, 4(2005)(PMID:15676080)
- Kozako T et al. Reduced frequency, diversity, and function of human T cell leukemia virus type 1-specific CD8+ T cell in adult T cell leukemia patients. J Immunol. 177, 5718-26 (2006)(PMID:17015761)
- Akimoto M et al. Anti-HTLV-1 tax antibody and tax-specific cytotoxic T lymphocyte are associated with a reduction in HTLV-1 proviral load in asymptomatic carriers. J Med Virol. 79, 977-86 (2007)(PMID:17516523)
- Tsukahara T et al. Prognostic impact and immunogenicity of a novel osteosarcoma antigen, papillomavirus binding factor, in patients with osteosarcoma. Cancer Sci. 99, 368-75 (2008)(PMID:18271936)
- Akiyama Y et al. Characterization of a MAGE-1-derived HLA-A24 epitope-specific CTL line from a Japanese metastatic melanoma patient. Anticancer Res. 29, 647-55 (2009)(PMID:19331215)
- Shima H et al. Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine. Cancer Immunol Immunother. 67, 1603-1609 (2018)(PMID:30069687)
- Watanabe K et al. Immunogenic enhancement and clinical effect by type-I interferon of anti-apoptotic protein, survivin-derived peptide vaccine, in advanced colorectal cancer patients. Cancer Sci. 110, 40-51 (2019)(PMID:30375705)
|